314 related items for PubMed ID: 27852974
1. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
[Abstract] [Full Text] [Related]
2. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
J Pediatr; 2015 Mar 01; 166(3):743-50. PubMed ID: 25557963
[Abstract] [Full Text] [Related]
3. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H, MEWPE-CAH Study Group.
Horm Res; 2001 Mar 01; 55(4):161-71. PubMed ID: 11598369
[Abstract] [Full Text] [Related]
4. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W, Schwarz HP.
Horm Res Paediatr; 2011 Mar 01; 75(4):264-8. PubMed ID: 21196707
[Abstract] [Full Text] [Related]
5. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
Clin Endocrinol (Oxf); 2002 Nov 01; 57(5):669-76. PubMed ID: 12390343
[Abstract] [Full Text] [Related]
6. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2007 May 01; 92(5):1635-9. PubMed ID: 17299071
[Abstract] [Full Text] [Related]
7. Congenital adrenal hyperplasia: lessons from a multinational study.
Frisch H, Waldhauser F, Lebl J, Solyom J, Hargitai G, Kovacs J, Pribilincova Z, Krzisnik C, Battelino T, MEWPE-CAH Study Group.
Horm Res; 2002 May 01; 57 Suppl 2():95-101. PubMed ID: 12065936
[Abstract] [Full Text] [Related]
8. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
[Abstract] [Full Text] [Related]
9. Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia.
Claahsen-van der Grinten HL, Noordam K, Borm GF, Otten BJ.
J Clin Endocrinol Metab; 2006 Apr 25; 91(4):1205-9. PubMed ID: 16464952
[Abstract] [Full Text] [Related]
10. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Trinh L, Nimkarn S, New MI, Lin-Su K.
J Pediatr Endocrinol Metab; 2007 Aug 25; 20(8):883-91. PubMed ID: 17937061
[Abstract] [Full Text] [Related]
11. [Growth and adult height in patients with congenital adrenal hyperplasia].
Kolousková S, Zemková D, Snajderová M, Lebl J.
Cas Lek Cesk; 1995 Nov 01; 134(21):689-91. PubMed ID: 8556761
[Abstract] [Full Text] [Related]
12. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D.
J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598
[Abstract] [Full Text] [Related]
13. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 01; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
14. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2009 Oct 01; 94(10):3882-8. PubMed ID: 19622620
[Abstract] [Full Text] [Related]
15. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
Endocr Pract; 2017 May 01; 23(5):546-556. PubMed ID: 28225306
[Abstract] [Full Text] [Related]
16. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
Indian J Pediatr; 2019 Feb 01; 86(2):154-158. PubMed ID: 30097840
[Abstract] [Full Text] [Related]
17. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
Turk J Pediatr; 2009 Feb 01; 51(6):539-44. PubMed ID: 20196386
[Abstract] [Full Text] [Related]
18. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method.
Bonfig W, Schwarz HP.
J Pediatr Endocrinol Metab; 2012 Feb 01; 25(7-8):645-9. PubMed ID: 23155688
[Abstract] [Full Text] [Related]
19. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP, Winter A, Stolecke H.
Klin Padiatr; 1997 Feb 01; 209(2):71-7. PubMed ID: 9113619
[Abstract] [Full Text] [Related]
20. Puberty and fertility in congenital adrenal hyperplasia.
Otten BJ, Stikkelbroeck MML, Claahsen-van der Grinten HL, Hermus ARMM.
Endocr Dev; 2005 Feb 01; 8():54-66. PubMed ID: 15722617
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
